Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pulmonary Embolism and Stroke in Patient With Patent Foramen Ovale (EPIC-FOP)

This study has been terminated.
(The study stooped because the answer to the primary objective is possible.)
Sponsor:
Information provided by (Responsible Party):
University Hospital, Brest
ClinicalTrials.gov Identifier:
NCT01216423
First received: September 29, 2010
Last updated: March 22, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2015
  Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)